“`html
Bioceres Crop Solutions Corp. (BIOX) reported a quarterly loss of $0.12 per share for the period ending September 2025, compared to a Zacks Consensus Estimate loss of $0.04 and a loss of $0.09 per share in the same quarter last year. The company’s revenues for the quarter were $77.3 million, which fell short of the consensus estimate by 18.37% and decreased from $92.6 million year-over-year.
This report represents an earnings surprise of -200.00%, and Bioceres has not exceeded consensus revenue estimates in its last four quarters. Year-to-date, the stock has plummeted by approximately 68.3%, contrasting with the S&P 500’s gain of 16.4%.
Looking ahead, the current consensus EPS estimate for the upcoming quarter is $0.07 on expected revenues of $112.4 million, while the annual estimate is -$0.21 on revenue projections of $353 million.
“`
